[pt] A falta de consciência dos déficits cognitivos ou da doença (ou anosognosia) é uma característica frequente na doença de Alzheimer (DA). No entanto, existe uma variabilidade na apresentação e na severidade da anosognosia em pacientes com DA. Com base no Cognitive Awareness Model (CAM), esta tese tem como objetivo explorar experimentalmente dois fatores que podem possivelmente influenciar a consciência das habilidades cognitivas, a saber, o estado de humor atual e a perspectiva através da qual a informação é apresentada, na DA. A primeira parte desta tese explora o impacto do estado de humor na consciência dos déficits. Como sugerido no CAM que vieses emocionais podem influenciar o acesso para memórias pessoais, consequentemente levando a anosognosia, uma revisão sistemática da literatura foi conduzida para entender melhor o efeito de memória congruente ao humor em adultos saudáveis (Article 1). Em seguida, apresentamos um estudo experimental investigando esta hipótese na DA (Article 2). Nesse estudo, estados de humor negativos e neutros foram experimentalmente induzidos usando quatro tarefas de Success-Failure Manipulation (SFM), duas tarefas com base no tempo de reação e duas com base na memória. Os resultados mostraram um aumento da consciência dos sintomas após a indução de humor negativo, mas somente quando a tarefa usada no SFM era com base na memória. A segunda parte deste trabalho investiga se a perspectiva através qual a informação é apresentada (auto vs. outro) influencia as habilidades metacognitivas de pacientes com DA. De fato, uma revisão da literatura destacou que estudos explorando o impacto da tomada de perspectiva na metacognição com diferentes populações neurológicas e psiquiátricas mostraram que os pacientes são capazes de reconhecer déficits em outros, apesar da apresentar uma falta de consciência das suas próprias dificuldades (Article 3). Em seguida, um estudo experimental foi conduzido pedindo para pacientes com DA e controles avaliar o seu próprio desempenho em quatro diferentes tarefas, assim como avaliar o desempenho de uma pessoa conhecida (cuidador/esposo/amigo) (Article 4). Nossos resultados destacam que, em geral ambos os grupos superestimaram mais quando avaliavam o desempenho de uma pessoa conhecida. No entanto, pacientes com DA tenderam a superestimar mais o desempenho em comparação com controles, mas somente no experimento envolvendo tarefas de memória. Em resumo, os resultados destes estudos dão suporte experimental a três aspectos sugeridos pelo CAM como fatores influenciando a consciência de déficits. Em primeiro lugar, as achados sobre a relação entre humor e consciência apoiam à ideia de vieses emocionais na memória como uma explicação parcial para anosognosia. Em segundo lugar, os resultados mostrando que os pacientes com DA avaliam o próprio desempenho de uma forma diferente em comparação a avaliação do desempenho de uma pessoa conhecida apoiam à inclusão de diferentes registros de memória para informações pessoais e para informações sobre os outros na versão reformulada do CAM. Em terceiro lugar, nossos achados mostrando diferenças nos resultados dependendo do tipo de tarefa usado no SFM (tempo de reação vs. memória) reforçam o conceito de uma consciência dos déficits como sendo multidimensional, conceito que está na base do aspecto modular do CAM. / [en] Lack of awareness about cognitive deficits or illness, also named anosognosia, is a common feature of Alzheimer s disease (AD). However, there is variability in the presentation and severity of anosognosia in patients with AD. Based on the Cognitive Awareness Model (CAM), this thesis aims to explore experimentally two factors which could possibly influence the awareness of cognitive abilities in AD, namely current mood state and the perspective through which the information is presented. The first section of this thesis explores the impact of mood state on awareness of deficits. As it has been suggested in the CAM that emotional biases could influence the access to personal memories, consequently leading to anosognosia, a systematic literature review was conducted to understand better the mood-congruent memory effect in healthy adults (Article 1). Then, we present an experimental study investigating this hypothesis in AD (Article 2). In this study, negative and neutral mood states were experimentally induced using four Success-Failure Manipulation (SFM) tasks, two based on reaction time tasks and the other on memory tasks. The results showed an improvement of awareness of symptoms after negative mood induction, but only when the task used in the SFM was memory-based. The second section of this work investigates if the perspective through which the information is presented (self vs. other) has an influence on metacognitive abilities of patients with AD. Indeed, a literature review highlighted that studies exploring the impact of perspective taking on metacognition with different neurologic and psychiatric populations showed that patients are able to recognize deficits in others, despite lack of awareness of their own difficulties (Article 3). Then, an experimental study was conducted by asking AD patients and controls to evaluate their own performance on four different tasks, as well as the performance of a well-known person (caregiver/spouse/friend) (Article 4). Our findings highlight that overall both groups made higher overestimation when evaluating the performance of a well-known person. However, AD patients tended to overestimate more the performance compared to controls but only in the memory experiment. In summary, results of these studies give experimental support to three aspects suggested by the CAM as factors influencing awareness of deficits. First, the findings on the relationship between mood and awareness support the idea of emotional biases in memory as a partial explanation for anosognosia. Second, the results showing that AD patients appraise the evaluation of selfperformance differently than the evaluation of a well-known person s performance support the inclusion of different memory records for self- and otherinformation in the reformulated version of the CAM. Third, by presenting differences in results depending on the type of task used in the SFM (reaction time vs. memory), our findings reinforce the concept that awareness is multidimensional, on which is based the modular aspect of the CAM.

The diploma thesis is aim at analysis of determinants that determine whether is the market of homes for the elderly and homes with special regime attractive for current and potential entrepreneurs. Theoretical part explains the phenomenom of population ageing, analyzes predictions of population development and the development of number of people suffering from Alzheimer disease, senior's financial resources, reasearches rights and duties of social services providers and analyzes effectiveness of financing the social services according to the type of founder. For needed findings is used analysis of specialized literature and studies. Analytical part analyzes preferences for examined kinds of social services. Offers practical example of running the home with special regime and brings the opinions of specialists on economization of social services. In the end of work are collected findings evaluate by means of SWOT analysis.

L’avènement du séquençage haut débit permet actuellement d’étudier et d’analyser la part de lacomposante génétique des maladies complexes médiée par les variants rares. Cependant, leurinterprétation représente un défi majeur. En effet, le séquençage de milliers d’exomes et degénomes a révélé la complexité du polymorphisme humain et notamment la surreprésentation devariants rares. Et malgré le développement de logiciels d’analyse ainsi que de différentes bases dedonnées, la priorisation des variants rares reste difficile. Dans le cadre de cette thèse, nous avons focalisé nos analyses sur les variations génétiques rares impliquées dans la maladie d’Alzheimer (MA). D’un point de vue génétique, la MA répond dans une majorité des cas à un déterminisme multifactoriel mais une minorité des cas sont des formes précoces à transmission autosomique dominante. La caractérisation des gènes PSEN1, PSEN2 et APP responsables des formes mendéliennes de MA a permis de formuler l’hypothèse de la cascade amyloïde en plaçant le peptide amyloïde (Aβ) au centre du processus physiopathologique. Afin de détecter de nouveaux facteurs de risque génétique dans la survenue de la MA, nous avons réalisé une étude d’association à partir de données de séquençage d’exomes de 522 cas atteints de formes précoces de MA et 584 contrôles. Les premières analyses ont porté sur les variants mononucléotidiques ainsi que les courtes insertions/délétions et ont permis de mettre en évidence un enrichissement en variants rares prédits délétères dans le gène ABCA7 chez les individus malades. Notre attention s’est ensuite portée sur les variations du nombre de copies (CNVs). L’absence de récurrence à l’échelle d’un gène nous a amené à travailler sur une liste de gènes. En nous focalisant sur l’hypothèse amyloïdergique, nous avons construit une liste de 342 gènes impliqués dans le métabolisme et la toxicité du peptide Aβ. Grâce à cette stratégie, nous avons ainsi réussi à mettre en évidence un enrichissement de CNVs rares intersectant ce réseau centré sur le peptide Aβ. Le résultat majeur de cette étude de CNVs a été la mise en évidence d’une duplication du locus 17q21.31 chez 5 patients atteints d’une maladie neurodégénérative similaire à une maladie d’Alzheimer. Les patients porteurs présentent un diagnostic clinique de MA, des biomarqueurs et une imagerie métabolique en faveur d’une neurodégénérescence de type Alzheimer. En revanche, l’imagerie amyloïde et l’analyse neuropathologique n’ont pas révélé de pathologie amyloïde et sont donc en faveur d’une tauopathie pure. L’étude des CNVs a également révélé une délétion partielle du gène PSEN1, emportant les exons 9 et 10, pour laquelle nous avons pu réaliser des études fonctionnelles. Nous avons ainsi pu déterminer que la protéine mutante favorisait la production de peptides amyloïdes plus longs, ces derniers étant des médiateurs majeurs de la neurotoxicité d’Aβ. / Next-generation sequencing allows studying and analyzing the genetic component part of complexdiseases mediated by rare variants. However, their interpretation represents a major challenge.Indeed, the sequencing of thousands of exomes and genomes revealed the human polymorphismcomplexity and in particular the overrepresentation of rare variants. Despite the development ofsoftwares and variant databases, the prioritization of rare variants remains arduous. My thesis subject was focused on the involvement of rare variants in Alzheimer's disease (AD). From a genetic point of view, AD is caused, in most cases, by a multifactorial determinism, but a minority of cases are autosomal dominant early-onset forms (ADEOAD). The characterization of mutations in the PSEN1, PSEN2 and APP genes as a cause of these Mendelian forms of AD led to the formulationof the amyloid cascade hypothesis, stating that the amyloid-β peptide (Aβ) is triggering the pathophysiological process. In order to detect new genetic risk factors involved in AD, we performed an association study using exome sequencing data from 522 cases with early-onset Alzheimer Disease and 584 controls. The first analyzes focused on single nucleotide variants and short insertions / deletions, and revealed an enrichment in cases of variants that are predicted to be deleterious in the ABCA7 genes. We then then focused on copy number variations (CNVs). The lack of recurrence at the gene-level incited us to work on a gene list. By focusing on the amyloidogenic hypothesis, we built a list of 342 genes involved in the metabolism and toxicity of the Aβ peptide. Thanks to this strategy, we found an enrichment of rare CNVs intersecting this Aβ network in cases.The main result of this CNV study was the identification of a duplication of the 17q21.31 locus in 5patients with a neurodegenerative disease similar to Alzheimer's disease. These patients have aclinical diagnosis of AD, as well as biomarkers and metabolic imaging consistent with an ADneurodegeneration. However, amyloid imaging and neuropathological analysis did not reveal anyamyloid pathology, and were therefore pointing to a pure tauopathy. This CNV study also revealed a partial deletion of the PSEN1 gene, overlapping exons 9 and 10, for which we performed functional studies. We demonstrated that the mutant protein enhanced the production of longer amyloid peptides, the latter being major mediators of Aβ neurotoxicity.

<p>Alchajmerova bolest je najče&scaron;ća demencija od svih demencija i karakteri&scaron;e je depozicija senilinih plakova i neurofibrilarnih klubadi u kortikalnim moždanim regionima, koje daljim razvojem bolesti postaju atrofične. Klinički se karakteri&scaron;e smetnjma na planu pamćenja, egzekutivnih funkcija, pažnje i ostalih kognitivnih funkcija uz odustsvo sposobnosti samostalnog funkcionisanja u svakodnevnom životu. Blagi kognitivni poremeća (BKP) je klinički entitet koji se smatra početnim stadijumom demencije u kom se registruju smetnje na planu pamćenja, ali i drugih kognitvnih funkcija, uz očuvanu funkcionalnost u svakodnevnom životu. Kod obe bolesti je utvrđeno da pored kortikalnog zahvatanja, patolo&scaron;kim procesom je zahvaćena i bela masa mozga. U dana&scaron;nje vreme se mirkostrukturno o&scaron;tećenje bele mase mozga može ispitati difuzionim tenzorskim imidžinogom (DTI) na magnentoj rezonanci mozga (MR). Cilj: Utvrditi razlike neuropsiholo&scaron;kih skorova i razlike DTI parametara između obolelih od AB, BKP i kontrolne grupe zdravih ispitanika, kao i utvrditi da li postoji korelacija između neuropsiholo&scaron;kih skorova i DTI parametara kod BKP i AB.&nbsp; Metode: U istraživanje je uključeno tri ispitivane grupe od po 30 ispitanika: oboleli od AB u blagom stadijumu bolesti, oboleli od amnestičkog multi-domen BKP i kontrolna grupa zdravih ispitanika. Dijagnoza kod obolelih u obe grupe je postavljena na osnovu kliničkih kriterijuma aktuelnih dijagnostičkih kriterijuma iz 2011. godine. Kod svih ispitanika je sprovedeno detaljno neuropsiholo&scaron;ko testiranje u cilju procene kognitivnih funkcija (smetnji na planu pamćenja, egzekutivnih funkcija, pažnje, govora, vizuospacijalnih i vizuokonstrukcionih sposobnosti), depresivnosti i drugih neuropsihijatrijskih simptoma i kvaliteta života. Samo je kod obolelih od AB dopunski vr&scaron;ena procena sposobnosti svakodnevnog funkcionisanja. Kognitivne funkcije su ispitane formiranjem kognitivnih domena, na osnovu pretpostavke o zajedničkom predmetu merenja kori&scaron;ćenih testova. Potom je načinjen MR mozga, u okviru koje je analiziran i DTI. Dalja obrada DTI je sprovedena primenom TBSS metode, čime su dobijene vrednosti DTI parametara: frakcione anizotropije (FA), srednje difuzivnosti (SD), radijalne difuzivnosti (RD) i aksijalne difuzivnosti (DA). Nakon toga je načinjena korelacija neuropsiholo&scaron;kog postignuća i DTI parametara kori&scaron;ćenjem Pirsonovog, odnosno Spirmanovog koeficijenta korelacije. Rezultati: Oboleli od AB su imali lo&scaron;ije postignuće na planu vizuelnog pamćenja, verbalnog pamćenja, neposrednog upamćivanja, odloženog prisećanja, pažnje, govora, egzekutivnih funkcija, mi&scaron;ljenja, radne memorije i vizuospacijalnih i vizuokonstrukcionih sposobnosti u odnosu na kontrolnu grupu zdravih. Oboleli od BKP su imali lo&scaron;ije postignuće u odnosu na kontrolnu grupu zdravih u domenima vizuelno pamćenje, neposredno upamćivanje, odloženo prisećanje, govor, mi&scaron;ljenje i vizuospacijalne i vizuokonstrukcione sposobnosti. Obe grupe obolelih su ispoljile vi&scaron;e depresivnih simptoma u odnosu na kontrolnu grupu zdravih ispitanika. Takođe, obe grupe obolelih ispoljavaju statistički značajno vi&scaron;e neuropsihijatrijskih simptoma u odnosu na zdrave ispitanike, gde se kod obolelih od AB registruju sumanute ideje, halucinacije, agitacija, euforija, dezinhibicija, ritabilnost i apatija, dok se kod obolelih od BKP registruju anksioznost i iritabilnost. Oboleli od AB imaju lo&scaron;iji kvalitet života u odnosu na zdrave ispitanike, dok između oboleli od BKP i zdravih ispitanika nema razlike u proceni kvaliteta života. &Scaron;to se tiče DTI parametara, oboleli od AB imaju niži FA i vi&scaron;u SD, RD i DA u odnosu na zdrave ispitanike na vi&scaron;e puteva bele mase: prednji krak kapsule interne, prednja korona radijata, telo korpusa kalozuma, cingulum, kapsula eksterna, fornix-strija terminalis, koleno korpusa kalozuma, donji fronto-okcipitalni fascikulus, zadnja korona radijata, gornji fronto-okcipitalni fascikulus, gornji longitudinalni fascikulus i fascikulus uncinatus. Oboleli od BKP imaju sniženu FA i povi&scaron;enu SD, RD i DA u regiji forniksa u odnosu na zdrave ispitanike. Kod obolelih od AB registrovane su značajne povezanosti mikrostrukturnog o&scaron;tećenja bele mase i o&scaron;tećenja svih kognitivnih domena, izuzev domena mi&scaron;ljenje, dok su kod obolelih od BKP registrovane značajne povezanosti mikrostrukturnog o&scaron;tećenja bele mase i o&scaron;tećenja svih kognitivnih domena, izuzev domena egzekutivne funkcije. U grupi obolelih od BKP je bilo vi&scaron;e registrovanih korelacija o&scaron;tećenja domena verbalno pamćenje, odloženo prisećanje i govor sa o&scaron;tećenjem bele mase mozga, dok je kod AB bilo vi&scaron;e registrovanih korelacija o&scaron;tećenja domena vizuelno pamćenje, neposredno upamćivanje, pažnja, radna memorija i vizuospacijalne i vizuokontrukcione sposobnosti sa o&scaron;tećenjem bele mase mozga. Depresivnost je jedino u grupi BKP značajno korelirala sa o&scaron;tećenjem određenih puteva bele mase mozga. Zaključak: U blagom stadijumu obolelih od AB se registruje kognitivno o&scaron;tećenje svih ispitivanih domena, vi&scaron;e su ispoljeni depresivni simptomi, utvrđen je veliki broj neuropsihijatrijskih simptoma i naru&scaron;en je kvalitet života u odnosu na zdrave ispitanike. Kod obolelih od BKP je registrovano kognitivno o&scaron;tećenje vi&scaron;e od pola procenjivanih kognitivnih funkcija, vi&scaron;e su ispoljeni depresivni simptomi i utvrđeno prisustvo anksioznosti i iritabilnosti, dok kvalitet života nije naru&scaron;en u ovoj fazi bolesti u odnosu na zdrave ispitanike. Rezultati vezani za mikrostrukturno o&scaron;tećenja mozga u najranijim fazama AB ukazuju da je neuronska mreža značajno o&scaron;tećena u najranijim kliničkim fazama bolesti, dok je u stadijumu BKP izolovana na o&scaron;tećenje u regiji forniksa. U grupi obolelih od BKP je bilo vi&scaron;e registrovanih korelacija o&scaron;tećenja domena verbalno pamćenje, odloženo prisećanje i govor sa o&scaron;tećenjem bele mase mozga, dok je kod AB bilo vi&scaron;e registrovanih korelacija o&scaron;tećenja domena vizuelno pamćenje, neposredno upamćivanje, pažnja, radna memorija i vizuospacijalne i vizuokontrukcione sposobnosti sa o&scaron;tećenjem bele mase mozga. Stepen depresivnosti i o&scaron;tećenje bele mase mozga je povezano isključivo na nivou BKP.</p> / <p>Alzheimer&#39;s disease (AD) is the most common dementia of all dementia with deposition of senile plaques and neurofibrillary tangles in cortical brain regions, which become atrophic in the further disease development. It`s main clinical characteristics are impairment of memory, executive function, attention and other cognitive functions with impairment in daily living activities. Mild cognitive impairment (MCI) is a clinical entity considered as an initial stage of dementia with present memory impairment, as well as other cognitive functions, while maintaining the functionality of the everyday life. In both diseases, pathological processes affect also the white matter of the brain. Nowadays, microstructural damage of the brain white matter is diagnosed by using diffusion tensor imaging (DTI) in the brain magnetic resonance imaging (MR). Objective: The aim of this study was to determine differences in neuropsychological scores and differences in DTI parameters between patients with AD, MCI and control groups of healthy subjects, as well as to determine whether there is a correlation between scores and DTI parameters in MCI and AD.&nbsp; Methods: The study included three groups of 30 patients each: of AD patients in the mild stage of the disease, patients with multi-domain amnestic MCI, and healthy controls. The patient&rsquo;s diagnosis are based upon clinical criteria of current diagnostic criteria proposed in 2011. All patients had assessment of cognitive functions (impairment of memory, executive function, attention, language, visuospatial and construction abilities), depressive symptoms and other behavioral disorders and quality of life. Only in patients with AD, we also assessed ability of daily living activities. Cognitive functions were tested by forming cognitive domains, based on the assumption of a common object of measurement of analyzed tests. Further, participants had MRI scan, in which DTI was analyzed. DTI post-processing was carried out by using TBSS method, whereby the values of DTI parameters were: fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (DA). We conducted correlation analysis of the neuropsychological achievements and DTI parameters using Pearson or Spearman&rsquo;s correlation coefficient, dependent on variable distribution. Results: The patients with AD had lower scores in the field of visual memory, verbal memory, immediate and delayed recall, attention, language, executive functions, reasoning, working memory and visuospatial and construction abilities compared to the control group. Patients with MCI had lower scores compared to the control group in the domains of visual memory, immediate and delayed recall, language, reasoning, and visuospatial and construction abilities. Both groups of patients have more depressive symptoms in relation to the control group of healthy subjects. In addition, both groups of patients exhibited a significantly higher degree of behavioral disorders as compared to healthy subjects, where AD patients experienced delusions, hallucinations, agitation, euphoria, disinhibition, irritability and apathy, while MCI patients experienced anxiety and irritability. Patients with AD had a poor quality of life compared to healthy subjects, whereas people with MCI did not. As for the parameters of DTI, AD patients had decrease of FA and increase of MD, RD, and DA compared to the healthy subjects in the multiple white matter tracts: anterior limb of internal capsule, anterior part of corona radiata, the body of the corpus callosum, cingulum, external capsule, fornix- striae terminalis, genu of the corpus callosum, inferior frontal-occipital fasciculus, posterior corona radiata, superior frontal-occipital fasciculus, superior longitudinal fasciculus and fasciculus uncinatus. Patients with MCI had decreased FA and increased MD, RD and DA in the fornix compared to healthy subjects. In AD patients, there was significant association between microstructural white matter brain damage and all cognitive domains, except domain reasoning, while in patients with MCI significant association was evident between microstructural white matter damage and all cognitive domains, except the domain of executive function. Results related to the microstructural white matter brain damage in mild AD indicates that wide neural network is significantly damaged at the earliest clinical stages of the disease, while in MCI stage only fornix shows microstructural white matter brain damage. Level of impairment of verbal memory, delayed recall and language correlates more frequently in MCI group compared to mild AD group, where impairment in the field of visual memory, immediate recall, attention, working memory and visuospatial and construction abilities correlates more frequently with white matter brain damage. Association of depressive symptoms and white matter brain damage was significant in MCI patients. Conclusion: In mild AD, cognitive impairment is present in all cognitive domains; patients experience more depressive symptoms and wider spectrum of behavioral disorders with compromised quality of life compared to healthy subjects. In MCI patients, cognitive impairment is present in more than half of the assessed cognitive functions; patients also experience more depressive symptoms, as well as anxiety and irritability without quality of life deterioration compared to healthy subjects. Results related to the microstructural white matter brain damage in mild AD indicates that wide neural network is significantly damaged at the earliest clinical stages of the disease, while in MCI stage only fornix shows microstructural white matter brain damage. Level of impairment of verbal memory, delayed recall and language correlates more frequently in MCI group compared to mild AD group, where impairment in the field of visual memory, immediate recall, attention, working memory and visuospatial and construction abilities correlates more frequently with white matter brain damage. The degree of depression correlated significantly with white matter brain damage solely at the level of MCI.</p>

La maladie d'Alzheimer (MA) est une maladie neurodégénérative dévastatrice qui touche un grand nombre de personnes. Elle entraîne des troubles de la mémoire et, éventuellement, une perte complète des fonctions cognitives. Le peptide amyloïde-β (Aβ) et la protéine associée aux microtubules tau sont généralement associés à la perte progressive de la mémoire. Dans les stades précoces, la MA se caractérise par une perturbation générale de l'efficacité synaptique. Les effets perturbateurs d'Aβ sur la plasticité à long terme sont bien documentés, par contre nos connaissances des effets immédiats du peptide sur la transmission synaptique sont limitées. Mon hypothèse est qu’Aβ ne nécessite pas une période prolongée pour promouvoir des changements de la transmission synaptique et qu’il peut modifier la fonction synaptique même après une exposition aiguë. Dans l’étude I, je test cette hypothèse à l’aide d’une exposition aiguë d'oligomères Aβ sur des tranches organotypiques d'hippocampe. Mes résultats indiquent qu’Aβ favorise une dépression synaptique sur les neurones pyramidaux hippocampiques avec une cinétique relativement rapide. Je démontre également que la dépression synaptique dépend de l'activation des récepteurs NMDA (NMDAR), mais ne dépend pas du flux d'ions à travers son canal ionique. Puisqu’il a été démontré que l'activation des NMDAR entraîne la phosphorylation de tau, il est plausible qu’Aβ modifie l'excitabilité des neurones en modulant la phosphorylation de cette protéine. Étant donné que les NMDAR jouent un rôle important dans la plasticité synaptique à long terme, cette chaîne d’événements moléculaires pourrait contribuer aux déficits de plasticité observés dans les phases initiales de la MA. Mon hypothèse est qu’Aβ modifie l’activité synaptique en modulant la phosphorylation de tau. Pour tester cette hypothèse, j’induis, dans des neurones de tranches de l’hippocampe, l’expression de formes de tau contenant des mutations qui bloquent la phosphorylation de la protéine aux sites ciblés. Dans l’étude II, j’observe que la phosphorylation de tau aux sites AT8 et AT180 régule l’expression de la plasticité synaptique ainsi que le dysfonctionnement de la transmission synaptique induits par les oligomères d’Aβ. Je démontre aussi que la phosphorylation du site PHF-1 ne contribue pas à la régulation de la plasticité et de la transmission synaptique. Puisque les sites AT8 et AT180 régulent l’interaction de la protéine tau avec la tyrosine kinase Fyn, mes résultats suggèrent que l’interaction entre tau et Fyn est importante pour l’expression de la plasticité synaptique et de la dépression favorisées par les oligomères d’Aβ. En effet, je démontre que l’inhibition de l’activité de la kinase Fyn résulte en un blocage de la dépression synaptique à long terme et un sauvetage de la fonction synaptique en présence d’Aβ. Je conclus que la phosphorylation de la protéine tau à des sites spécifiques est indispensable à l’expression de la plasticité synaptique et j’émets l’hypothèse que les oligomères d’Aβ modifient l'activité synaptique en influençant la stabilité du complexe Fyn-tau. Je propose donc que la perturbation de la stabilité de ce complexe peut être utilisée en thérapie pour inverser les déficits synaptiques dans les stades précoces de la MA. / Alzheimer disease is the most common form of dementia; it is characterized by problems in memory formation, which with time leads to a complete loss of cognitive functions. The peptide amyloid-β (Aβ) and the microtubule-associated protein tau are commonly believed to be responsible for the decline in memory formation. In the early stages of AD, this is thought to happen through a general disruption in synaptic efficiency. The disruptive effects of Aβ on long-term plasticity are well documented; however, little is known about the immediate effects of the peptide on synaptic transmission. My hypothesis is that Aβ does not need a prolonged period to promote changes in synaptic transmission, and that the peptide is able to affect synaptic function even after an acute exposure. In study I, I investigate this hypothesis using an acute exposure of Aβ oligomers to organotypic hippocampal slices. I report that Aβ promotes synaptic depression on hippocampal pyramidal neurons with a fairly rapid kinetic. I also show that the synaptic depression is dependent on the activation of the NMDAR, but independent on the ion flux through the channel. Because it was shown that the activation of the NMDAR leads to phosphorylation of tau, it appears feasible that Aβ modifies neuronal excitability by modulating tau phosphorylation. Since the NMDAR plays a critical role in the induction of long-term plasticity, this cascade of events could contribute to the deficits in plasticity observed during the initial stages of AD. My hypothesis is that Aβ modifies synaptic activity by modulating phosphorylation on tau. To test this hypothesis, I express in hippocampal neurons tau mutants in which phosphorylation on specific sites is blocked. In study II, I report that phosphorylation on tau at the AT8 and AT180 sites regulates the expression of synaptic plasticity as well as the dysfunction in synaptic transmission induced by Aβ oligomers. I also show that phosphorylation at the PHF-1 site is not involved in mediating either effects. Since the AT8 and AT180 sites regulate the interaction of tau protein with the tyrosine kinase Fyn, my results suggested that the interaction between tau and Fyn is important for the expression of synaptic plasticity and the depression mediated by Aβ oligomers. Indeed, I show that inhibiting the activity of Fyn kinase results in a block of LTD and a rescue of synaptic function in presence of Aβ. I conclude that phosphorylation of tau at specific sites is mandatory for the expression of synaptic plasticity, and suggest that Aβ oligomers promote changes of synaptic activity by influencing the stability of the tau-Fyn complex. I therefore propose that disrupting the stability of this complex can be exploited therapeutically to rescue synaptic deficits in the initial stages of AD.

No / Mammalian glycogen synthase kinase-3 (GSK3) is generated from two genes, GSK3alpha and GSK3beta, while a splice variant of GSK3beta (GSK3beta2), containing a 13 amino acid insert, is enriched in neurons. GSK3alpha and GSK3beta deletions generate distinct phenotypes. Here, we show that phosphorylation of CRMP2, CRMP4, beta-catenin, c-Myc, c-Jun and some residues on tau associated with Alzheimer's disease, is altered in cortical tissue lacking both isoforms of GSK3. This confirms that they are physiological targets for GSK3. However, deletion of each GSK3 isoform produces distinct substrate phosphorylation, indicating that each has a different spectrum of substrates (e.g. phosphorylation of Thr509, Thr514 and Ser518 of CRMP is not detectable in cortex lacking GSK3beta, yet normal in cortex lacking GSK3alpha). Furthermore, the neuron-enriched GSK3beta2 variant phosphorylates phospho-glycogen synthase 2 peptide, CRMP2 (Thr509/514), CRMP4 (Thr509), Inhibitor-2 (Thr72) and tau (Ser396), at a lower rate than GSK3beta1. In contrast phosphorylation of c-Myc and c-Jun is equivalent for each GSK3beta isoform, providing evidence that differential substrate phosphorylation is achieved through alterations in expression and splicing of the GSK3 gene. Finally, each GSK3beta splice variant is phosphorylated to a similar extent at the regulatory sites, Ser9 and Tyr216, and exhibit identical sensitivities to the ATP competitive inhibitor CT99021, suggesting upstream regulation and ATP binding properties of GSK3beta1 and GSK3beta2 are similar.

Réalisée en cotutelle avec l'Unité de Formation à la Recherche Lettres Arts et Sciences Humaines - Université Nice-Sophia Antipolis. / La survenue de modifications cérébrales issues du vieillissement normal ou provoquées par la maladie d’Alzheimer entraîne un certain bouleversement de l’attention visuelle sélective, soit la capacité à centrer volontairement les mécanismes de perception sur un stimulus particulier en négligeant les stimuli non pertinents. A ces modifications viennent s’ajouter des phénomènes de réorganisations cérébrales qui peuvent s’illustrer sur l’axe inter-hémisphérique par une réduction de la latéralisation cérébrale dans le vieillissement normal et sur l’axe intra-hémisphérique par un accroissement de l’engagement des régions frontales et préfrontales dans le vieillissement normal et la maladie d’Alzheimer. Toutefois, les mécanismes sur lesquels reposent ces phénomènes de réorganisations cérébrales dans le vieillissement normal et la maladie d’Alzheimer dans le contexte de l’attention visuelle restent peu compris. Ce travail de thèse s’intéresse à la nature de la réorganisation cérébrale dans le vieillissement normal (inter-hémisphérique vs. intra-hémisphérique) en condition d’attention visuelle sélective et s’inscrit dans le modèle de la réserve cognitive afin de préciser la nature des mécanismes sous-jacents de la réorganisation cérébrale (réserve neurale vs. compensation neurale). Concernant la maladie d’Alzheimer, ce travail met l’emphase sur la dynamique inter-hémisphérique et son principal substrat anatomique, le corps calleux, afin d’étudier l’efficience des mécanismes inter-hémisphériques. Dans l’ensemble de cette thèse, le substrat (fonctionnel et anatomique) de la réorganisation cérébrale est étudié en manipulant la complexité, ce qui permet d’identifier le mode d’adaptation face à l’accroissement de la demande cognitive soit, les mécanismes qui permettent de faire face au vieillissement normal et aux troubles de la cognition mais aussi d’étudier l’efficience de ces mécanismes. Le premier chapitre présente l’attention sélective, ses modifications neuro-fonctionnelles et les divers phénomènes de réorganisations cérébrales connus au cours du vieillissement normal et dans la maladie d’Alzheimer. Le cadre théorique dans lequel s’inscrit cette thèse, celui de la réserve cognitive, et la problématique du travail de recherche sont également décrits en fin de chapitre. La recherche effectuée est ensuite rapportée sous forme de 5 chapitres distincts. Enfin, les concepts théoriques évoqués par la revue de la littérature et les résultats des expérimentations font l’objet d’une discussion générale. Le deuxième chapitre de cette thèse (Article 1), visant à effectuer une revue de la littérature concernant les aspects inter-hémisphériques, permet de préciser, pour la première fois dans le domaine, le rôle du couplage inter-hémisphérique des ressources cérébrales dans la réorganisation au cours du vieillissement normal, mais aussi de considérer l’effet du découplage dans la maladie d’Alzheimer. Le troisième chapitre (Article 2) explore les mécanismes de réorganisation cérébrale dans le vieillissement normal face à l’accroissement de la charge attentionnelle au niveau perceptif de l’attention sélective (i.e., appariement perceptuel, A-A). Les résultats montrent un patron de réorganisation intra-hémisphérique chez les âgés, sous-tendu en situation de faible charge attentionnelle (i.e., 3 lettres) par la compensation neurale mais qui se voit associée à l’implication concomitante de la réserve neurale en situation de charge attentionnelle élevée (i.e., 5 lettres). Ce travail montre, par conséquent, une certaine flexibilité dans le déploiement de ces mécanismes qui apparaît modulé par la demande cognitive de la tâche. Le quatrième chapitre (Article 3) examine ces mêmes mécanismes de réorganisation dans le vieillissement normal, dans le même contexte attentionnel en ayant recours à un niveau de charge attentionnelle faible (i.e., 3 lettres) et à un niveau de charge attentionnelle élevé (i.e., 5 lettres), mais à un niveau plus complexe de l’attention sélective du fait qu’il implique une opération d’appariement basée sur le nom de la lettre (i.e., appariement nominatif, a-A). Les résultats montrent une amplification du renversement postéro-antérieur avec l’âge sur l’axe intra-hémisphérique face à l’accroissement de la charge attentionnelle (i.e., 5 lettres), suggérant ainsi que ce renversement est exclusivement lié à l’âge et qu’il repose principalement sur le mécanisme de compensation neurale. Le cinquième chapitre (Article 4) présente deux études dans lesquelles la présentation d’une tâche d’appariement de lettres en champ visuel divisé et l’IRM morphologique du corps calleux ont été couplées. L’objectif de cette étude était d’examiner la relation entre les variations de volume du corps calleux et la dynamique inter-hémisphérique chez des participants âgés atteints de la Maladie d’Alzheimer, de troubles cognitifs légers ou qui connaissent un vieillissement normal. La première étude se situait au niveau perceptuel et concernait 3 groupes de participants (Maladie d’Alzheimer vs trouble cognitif léger vs vieillissement normal). La deuxième étude concernait les participants atteints de trouble cognitif léger et des participants âgés contrôles sains et comportait deux tâches avec deux conditions de complexité chacune, une tâche dans laquelle la complexité varie selon le type de jugement - appariement perceptuel (e.g., A-A) vs. nominatif (e.g., a-A) - et une dans laquelle la complexité varie selon la charge attentionnelle (i.e., 3 lettres vs. 5 lettres). Les mesures IRM correspondent au volume total du corps calleux et à cinq volumes régionaux : C1-Rostrum, Genou et partie antérieure du tronc, C2-partie médiane, C3-partie caudale, C4-Isthme et C5-Splenium. Ces deux études montrent que le volume du corps calleux semble affecter la mise en jeu de l’effet facilitateur du traitement inter-hémisphérique selon l’état cognitif des participants et la nature de la demande cognitive mise en jeu. Cet impact modulateur semble partiellement déterminé dans la maladie d’Alzheimer par les portions plus antérieures du corps calleux (C2) et, via l’ensemble du corps calleux dans le vieillissement normal (C2, C3, C4). En revanche cette modulation semble déficitaire chez les participants atteints de trouble cognitif léger et reliée à une atrophie du corps calleux chez les participants atteints de trouble cognitif léger. Enfin, le chapitre 6 constitue la discussion générale de la thèse. L’ensemble des résultats est résumé et discuté en rapport aux différents modèles de la réorganisation cérébrale, de la réserve cognitive et de la dynamique hémisphérique. / Normal aging and disrupt selective visual attention – the ability to focus perceptual mechanisms on target stimuli by neglecting irrelevant stimuli. These modifications are accompanied by brain reorganization on both interhemispheric (hemispheric asymmetry reduction) and intrahemispheric (posterior-anterior shift) dimensions. However, the mechanisms underlying this brain reorganization in the context of visual attention in normal aging and Alzheimer’s disease remain largely unknown. The goal of this dissertation is to better understand the nature of brain reorganization for visual selective attention, as well as the functional neural changes and the anatomical modification in normal aging and in cognitive impairment in nthe ederly. In normal aging, this research focuses on the nature of the brain reorganization (interhemispheric vs. intrahemispheric) in the context of visual selective attention and based on the cognitive reserve model to differentiate the underlying mechanisms (neural reserve vs. neural compensation). It also focuses on Alzheimer’s disease in the context of interhemispheric dynamics and its main anatomical substrate, the corpus callosum. Throughout this dissertation, the substrate (functional and anatomical) of brain reorganization is examined by manipulating the cognitive demand associated with the tasks to better understand the mechanisms applied to cope with normal aging and cognitive impairment. The first chapter introduces the concepts of selective attention, neurofunctional changes in normal aging and cognitive impairment, and the cognitive reserve model before introducing the present research topic. The second chapter (Article 1) reviews the contribution of hemispheric coupling to the preservation of cognitive abilities with age and its uncoupling in Alzheimer’s disease. In this review, the variable contribution of the adaptive callosal mechanism is discussed with reference to successful aging and Alzheimer’s disease. The third (Article 2) and fourth chapters (Article 3) report studies conducted with functional magnetic resonance imaging (fMRI). The purpose of these studies was to investigate to what extent and how the neural reserve and neural compensation mechanisms contribute to coping with normal aging in two contexts of visual selective attention: simple perceptual processing and more complex naming processing. In both studies, the complexity of processes was also manipulated by varying the attentional load related to the number of stimuli to be processed (low: 3 letters vs. high: 5 letters). The results for the perceptual matching study, reported in the third chapter, support the neural compensation hypothesis of cognitive reserve, as the activations regions underlying task performance differed in the younger and older groups. The older group recruited bilateral frontal superior gyri more than the younger one, as in the PASA (posterior-anterior shift in aging) phenomenon, from the lowest attentional load level. In addition, the elderly were found to use compensation and neural reserve concurrently to cope with increasing attentional load for perceptual processing. The results for the naming matching study, reported in the fourth chapter, indicate a load-dependant PASA, supporting the hypothesis that an enhancement of compensatory mechanism is required for the most complex processing. The fifth chapter (Article 4) presents studies investigating the interhemispheric dynamic, using variants of the letter matching paradigm, where cognitive demand is parametrically varied, along with 3D callosal total and regional volume measured, in individuals with Alzheimer disease and amnestic-mild cognitive impairment as well as age-matched healthy individuals. The results show that the relationship between the corpus callosum volume and the across-field advantage emerges for the lowest cognitive demand level in participants with Alzheimer disease but exclusively at high cognitive demand levels in normal aging; this suggests the existence of an interhemispheric compensation mechanism in Alzheimer disease based on the integrity of the corpus callosum and similar processes to those that allow the normal aging brain to cope with cognitive demand. These mechanisms are deficient in amnestic-mild cognitive impairment individuals in the high attentional load condition, due to callosal atrophy. In chapter six the nature of mechanisms to cope with aging and cognitive impairment is discussed, addressing the two main dimensions of brain reorganization: intrahemispheric and interhemispheric. In normal aging, cerebral reorganization of visual selective attention implies an intrahemispheric PASA phenomenon based on neural compensation. To cope with increased cognitive demand, neural reserve can also be recruited in basic perceptual processing, while the recruitment of compensation mechanisms increases in more complex processing of visual selective attention. Our study suggests that compensation and reserve are flexible, adaptive and deployed according to the cognitive demand and the type of processing required. In cognitive impairment, our study suggests the existence of an interhemispheric compensation mechanism in Alzheimer’s disease based on integrity of the corpus callosum and similar processes to those that allow the normal aging brain to cope with cognitive demand. This study provides evidence that interhemispheric interactions, supported by the corpus callosum, constitute a flexible mechanism that can improve the brain’s ability to handle processing demands and thus may compensate for the neural decline in Alzheimer’s disease in low cognitive demand situations.

De récents travaux ont mis en évidence que des dysfonctionnements dans l’expression de gènes impliqués dans la plasticité synaptique contribuent aux déclins cognitifs qu’on observe chez les gens âgés et à la progression de la maladie d’Alzheimer. Notre étude avait comme objectif d’étudier le profil d’expression d’ARNm spécifiques impliqués dans la plasticité synaptique chez des rats jeunes et âgés et chez des souris transgéniques 3xTg et WT. Des expériences en qRT-PCR ont été effectuées dans des extraits de cortex et d’hippocampe de rats jeunes et âgés et de souris 3xTg et WT, respectivement. Les résultats ont démontré une augmentation significative de l’expression d’ARNm MAP1B, Stau2, BDNF, CREB et AGO2 principalement dans l’hippocampe (régions CA1-CA3) des souris 3xTg comparé aux souris WT. Une diminution significative a également été observée pour l’ARNm αCaMKII dans le cortex des souris 3xTg comparé aux souris WT. Contrairement à ces observations, aucun changement n’a été observé pour l’expression de gènes impliqués dans la plasticité synaptique chez les rats âgés comparé aux rats jeunes. Ces résultats démontrent qu’un dysfonctionnement existe réellement au début de la maladie d’Alzheimer dans l’expression de gènes spécifiques impliqués dans la plasticité synaptique et contribue potentiellement à la progression de la maladie en engendrant un déséquilibre entre la LTP et la LTD. De plus, les différences d’expressions sont particulièrement observées dans l’hippocampe (régions CA1-CA3) ce qui est consistant avec les études sur la progression de la maladie d’Alzheimer puisqu’il est connu que la région CA1 de l’hippocampe est la plus vulnérable à l’apparition de la maladie. Ces résultats permettent une meilleure compréhension des événements moléculaires qui deviennent dérégulés à l’apparition de la maladie d’Alzheimer. / Recent work has demonstrated that dysregulations in the expression profile of plasticity-related genes in specific brain regions contribute to age-related cognitive decline and Alzheimer’s disease. The aim of this study was to determine the expression profile of a subset of plasticity-related mRNAs in different regions of the brain of young and aged rats as well as 3xTg and wild type (WT) mice. qRT-PCR experiments were performed in extracts of cortex and hippocampus of young and aged rats and of 3xTg and WT mice, respectively. Results demonstrated significant increases in the expression of MAP1B, Stau2, CREB, BDNF, and AGO2 mRNAs, especially in the hippocampus (CA1-CA3 fields) of 3xTg mice compared to WT mice. A significant decrease was also observed in the expression of αCaMKII mRNA in the cortex of 3xTg mice compared to WT mice. On the other hand, no significant changes were observed in the expression of plasticity-related genes in the hippocampus of aged rats compared to young rats. These results confirm that alterations in gene expression occur at the onset of AD and possibly contribute to the progression of the disease by causing an imbalance between long-term potentiation and long-term depression. In addition, patterns of significant altered gene expression, especially in the hippocampus (CA1-CA3 fields) of 3xTg mice are consistent with the progression of AD whereby the hippocampus (CA1 region) is most vulnerable at the onset of the disease. These results provide a better understanding of the molecular events that first become disturbed in AD.

Introdução: segundo a literatura, sais de lítio podem produzir redução da função renal. A magnitude dessa informação é debatível, uma vez que não há estudo clínico randomizado e controlado entre usuários de lítio, em sua maioria pacientes com depressão ou transtorno bipolar. A possibilidade do uso do lítio para o tratamento da demência de Alzheimer prodrômica reforça a necessidade de maior investigação de efeitos adversos atribuídos ao lítio, especialmente com relação à função renal. Objetivos: avaliar a segurança da utilização do lítio em baixa dosagem com relação à função renal de pacientes idosos. Como objetivos secundários serão avaliadas: a segurança clínica através de exame e questionário específico, as funções tireoidiana, imunológica e o metabolismo glicêmico. Métodos: estudo randomizado e placebo controlado de 2 anos, seguido de fase aberta por mais 2 anos. Foram avaliados 59 idosos com comprometimento cognitivo leve com seguimento mínimo de dois anos (fase controlada). A função renal foi estimada através das fórmulas aMDRD e CKD- EPI, a partir de exames laboratoriais e dados clínicos coletados durante o estudo. As funções tireoidiana, imunológica e glicêmica foram avaliadas respectivamente através de TSH, T4 livre, leucócitos total, neutrófilos, linfócitos, glicemia e insulinemia de jejum, e HOMA-IR. A segurança clínica foi avaliada através de entrevista sistemática realizada a cada 3 meses, utilizando exame físico e a escala UKU para efeitos adversos. Resultados: não houve piora da função renal com o uso do lítio (litemia entre 0,25-0,5 mmol/l) tanto pela aMDRD (p=0,453) como pela CKD-EPI (p=0,181). Houve aumento significativo de neutrófilos (p=0,038) e do TSH (p=0,034). O grupo lítio apresentou incidência significativamente maior de diabetes mellitus (p=0,037) e arritmias (p=0,028), maior ganho de peso (p=0,015), mais sintomas na escala UKU (p=0,045), e maior interferência dos efeitos adversos do lítio em atividades diárias (p<0,001). Houve correlação entre a opinião de médico e do paciente nas interferências das atividades diárias atribuídas aos sintomas adversos (p<0,001). Conclusões: o uso de lítio em baixa dose não alterou a função renal, produziu alterações no sistema imunológico e tireoidiano sem impacto clínico, e foi seguro clinicamente. As razões do aumento de incidência de diabetes e arritmias merecem investigação posterior / Introduction: according to the literature, lithium salts may produce a reduction in kidney function. The magnitude of this information is debatable because there is no randomized and controlled clinical trial among lithium users, being mostly patients with depression or bipolar disorder. The possibility of using lithium for the treatment of prodromal Alzheimer\'s disease dementia increases the need for further investigation of adverse effects attributed to lithium, especially regarding to renal function. Objectives: To evaluate the safety of using low-dose lithium with respect to renal function in elderly patients. Secondary objectives were the evaluation of the clinical safety through specific questionnaire and clinical assessment, and to assess thyroid, immunological and glycemic function. Methods: a randomized and placebo controlled study for 2 years, followed by an open label follow-up of 2 years. We evaluated 59 elderly patients with mild cognitive impairment with accomplishment of at least two years of the controlled phase. Renal function was estimated by the aMDRD and CKD-EPI equation, and by laboratory and clinical data collected during the trial. The thyroid, immunological and glycemic functions were respectively evaluated by TSH, free T4, leukocyte count, neutrophil count, lymphocyte count, fasting plasma glucose and insulin, and the HOMA-IR. The clinical safety was evaluated through systematic examination performed every 3 months, with physical examination, clinical interview and UKU scale for adverse effects. Results: There was no decline of renal function with the use of lithium (litemia between 0.25-0.5 mmol/l) both in the aMDRD (p=0.453) and CKD-EPI (p=0.181) equations. A significant increase of neutrophils (p=0.038) and TSH (p=0.034) were observed. The lithium group showed significantly higher incidence of diabetes mellitus (p=0.037), arrhythmias (p=0.028), weight gain (p=0.015), more symptoms of UKU scale (p=0.045), and greater interference from the adverse effects of lithium during daily activities (p<0.001). There was an observed correlation between the opinion of the attending physician and the patient in respect to the interference in daily activities secondary to the adverse symptoms (p<0.001). Conclusions: The use of lithium in low doses did not result in renal function impairment, produced subtle changes in the immunological system and thyroid function, and was clinically safe for adverse effects. The reasons for the increased incidence of arrhythmias and diabetes mellitus deserve further investigation

A inibição do transporte axonal é um evento que ocorre prematuramente no curso das doenças neurodegenerativas, inclusive antes da formação dos agregados proteicos, os quais estariam envolvidos no processo fisiopatológico das doenças neurodegenerativas. No presente estudo avaliou-se a hipótese de que alterações no transporte de mitocôndrias ocorrem antes da formação dos agregados proteicos envolvidos em neurodegeneração, devido a desregulação dos níveis citoplasmáticos de Ca2+ e o envolvimento da modulação do transporte mitocondrial provido pela proteína Miro neste cenário. Utilizaram-se dois modelos experimentais: o primeiro utilizando a exposição à rotenona em culturas primárias de neurônios do locus coeruleus, hipocampo e substância negra de ratos, e o segundo utilizando neurônios derivados de células tronco de pluripotência induzida (iPSC), isogênicas humanas contendo mutações que levam à deleção do exon 9 da (deltaE9) no gene da presenilina 1 (PS1), o qual apresenta aumento da síntese do peptídeo beta-amiloide com 42 aminoácidos (Abeta42), sem a formação de agregados proteicos. Os resultados mostram disfunções nos níveis citoplasmáticos de Ca2+ em ambos modelos. A mobilidade mitocondrial alterou-se no hipocampo, locus coeruleus e substância negra após exposição à rotenona. No entanto, a direção das alterações observadas não se correlacionaram com os níveis de Ca2+, de acordo com o já descrito na literatura. Não houve alteração da mobilidade mitocondrial, nem nos níveis de Miro1, nos neurônios derivados de iPSC. Em conclusão, o presente estudo demonstrou que alterações nos níveis citoplasmáticos de Ca2+ ocorrem antes e durante a formação de agregados proteicos, o que pode ser importante para a etiologia de doenças neurodegenerativas. Foi também demonstrado que mudanças na mobilidade mitocondrial, acompanhadas por alterações nas concentrações intracelulares de Ca2+, em níveis fisiológicos, ocorrem de forma independente dos níveis da proteína Miro1 em culturas de células. Porém são necessários novos estudos a fim de relacionar alterações na mobilidade mitocondrial e a indução da neurodegeneração / The axonal transport impairment occurs early in neurodegenerative diseases, even before the formation of protein aggregates, which are related with the neuropathophysiology mechanism in neurodegenerative diseases. In this study, we evaluate the hypothesis that disruptions in mitochondria transport occurs before the formation of protein aggregate related with neurodegeneration, triggered by dysregulations in cytosolic Ca2+ levels and the involvement of Miro Ca2+ dependent mechanism of mitochondria trafficking modulation. We employed two experimental models, first using rotenone exposure in primary neuronal cell cultures from locus coeruleus, substantia nigra and hippocampus of newborn rats. Second, using isogenic human neurons derived from induced pluripotent stem cells (iPSCs), harboring mutations, those induce exon 9 deletion (deltaE9) in Presenilin 1 (PS1) gene, and showing increased synthesis of amyloid beta peptide with 42 amino acids (betaA42) without the formation of protein aggregates. We found abnormalities in cytosolic Ca2+ levels in both experimental models, mitochondria trafficking were altered in hippocampus, substantia nigra and locus coeruleus. However, the pattern of mitochondria trafficking alterations did not correlate with cytosolic Ca2+ levels, accordingly with the data that was already published. We did not find alterations in mitochondria trafficking or Miro1 levels in neurons derived from iPSC. In conclusion, our finds demonstrated aberrant cytosolic Ca2+ levels before and during protein aggregation, which may be important for the etiology of neurodegenerative diseases. In addition, this dysfunction in mitochondria trafficking happens after changes in cytosolic Ca2+ levels, in physiological range, independent of Miro1 levels in primary neurons cell cultures. Therefore, new studies need to be done, aiming to elucidate the relation between mitochondria trafficking dysfunctions and the induction of neurodegeneration process.